Alkermes reiterates $400M-$420M Q4 proprietary net sales outlook while targeting mid-2027 alixorexton Phase III data
Source: Seeking Alpha ·
Read the full story at Seeking Alpha
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.